13F-HR filed by Nextech Invest Ltd.
Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:29:04 UTC, with 18 holding rows worth $2,232,309,227.
- Accession
- 0001595430-26-000015
- Filer
- CIK 1595430
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 18 entries on the cover page, a total value of $2,232,309,227 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,232,309,227 with VALUE read as dollars as filed, 13F file number 028-25607. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 7,601,087 | $1,560,199,118 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 4,663,176 | $150,573,953 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 6,776,506 | $122,315,933 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 7,162,637 | $96,480,720 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 3,447,482 | $75,396,431 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,550,998 | $33,631,875 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 1,835,139 | $31,454,282 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 278,896 | $31,177,784 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 2,636,225 | $29,657,531 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,113,946 | $29,508,430 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,693,140 | $18,506,020 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 4,449,932 | $12,103,815 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 766,000 | $11,742,780 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 761,153 | $9,080,555 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 416,700 | $8,417,340 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 450,000 | $5,184,000 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 2,324,943 | $4,649,886 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,419,355 | $2,228,774 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001595430-26-000015 | this filing | 2026-11-16 |